« Back
Home /
Dabrafenib (Mesylate)

Dabrafenib (Mesylate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	100 mg
Quantity options	100 mg 10mM/1mL 10 mg 500 mg 50 mg 5 mg
Item no.	HY-14660A-100mg
Targets	Raf
CASRN	1195768-06-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	GSK2118436 Mesylate; GSK 2118436B
Purity	99.95
Product Description	Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	615.67
Clinical_Information	Launched
Manufacturers Research Area	Cancer
Solubility	DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	Raf
Isoform	BRaf; c-Raf
Pathway	MAPK/ERK Pathway

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-14660A-100mg-safety-datasheet.pdf